Miskolczi P, Vereczkey L, Szalay L, Göndöc C
Department of Pharmacokinetics and Drug Metabolism, Chemical Works of Gedeon Richter Ltd., Budapest, Hungary.
Eur J Clin Pharmacol. 1987;33(2):185-9. doi: 10.1007/BF00544565.
The pharmacokinetics of vinpocetine and its main metabolite, apovincaminic acid (AVA), were studied in the aged. Vinpocetine was eliminated with a mean half-life of 2.12 +/- 0.51 h. Total plasma clearance (CL) and distribution coefficient (delta) of the parent drug were 2.2 +/- 0.9 l.kg-1.h-1 and 6.7 +/- 3.7 l.kg-1, respectively. The CL and delta of vinpocetine differed significantly from young subjects but the elimination half-life was not altered. Significant changes in the elimination half-life and plasma clearance of AVA were found, perhaps because of the physiological decrease in renal function.
研究了长春西汀及其主要代谢产物阿朴长春胺酸(AVA)在老年人中的药代动力学。长春西汀的消除半衰期平均为2.12±0.51小时。母体药物的总血浆清除率(CL)和分布系数(δ)分别为2.2±0.9升·千克⁻¹·小时⁻¹和6.7±3.7升·千克⁻¹。长春西汀的CL和δ与年轻受试者有显著差异,但消除半衰期未改变。发现AVA的消除半衰期和血浆清除率有显著变化,这可能是由于肾功能的生理性下降所致。